Annually, the HDA Research Foundation undertakes research projects to educate and inform pharmaceutical supply chain stakeholders as they work daily to achieve healthcare efficiencies. The publications featured in this section may be downloaded at no additional cost from HDA's Resources webpage.
HDA Factbook: The Facts, Figures and Trends in Healthcare
In its 88th year, the HDA Factbook provides data metrics and benchmarking on the traditional pharmaceutical supply chain.
Sponsors: Apotex Corp.; and Hospital Pharmaceutical Consulting (Silver); Amneal Pharmaceuticals; Pharmacy First; Smith Drug Company, Div. JM Corporation; and Teva Pharmaceuticals USA. (Bronze)
The Specialty Pharmaceutical Distribution: Facts, Figures and Trends report is a go-to resource for benchmarking data on specialty distribution and insight into the specialty pharmaceutical marketplace.
Sponsors: CuraScript SD (Platinum); Genentech Inc., A Member of the Roche Group; and Value Drug Company (Silver); Pharmacy First; Sensitech inc.; and Smith Drug Company, Div. J M Corporation. (Bronze)
Through industry knowledge, interviews and survey results, The Role of Reverse Distribution report highlights the complex reverse distribution process and opportunities for future enhancement.
Sponsors: PharmaLink, Inc. (Silver); Guaranteed Returns (Bronze)
This report analyzes the current market for biosimilars in the U.S. through interviews conducted with senior executives from specialty pharmaceutical manufacturing and distribution companies.
This turnkey PowerPoint presentation for presenters/trainers, as well as industry stakeholders, examines how the pharmaceutical supply chain operates and discusses the economics of traditional distribution.
This turnkey PowerPoint presentation for presenters/trainers, as well as industry stakeholders, examines how the specialty pharmaceutical supply chain operates and discusses the economics of specialty pharmaceutical distribution.
Conducted in fall 2018, this survey details pharmaceutical manufacturers’ readiness to meet the product serialization requirements of the Drug Supply Chain Security Act (DSCSA), including when distributors can expect to begin receiving serialized product and associated data.
Sponsors: LSPediA and WDSrx - Woodfield Distribution, LLC.
Through interviews, survey work and secondary data, The Role of Distributors in the U.S. Pharmaceuticals Value Chain explores the critical role distributors play to ensure the efficient and effective distribution of specialty medications.
Sponsors: Anda Inc.; Boehringer Ingelheim Pharmaceuticals, Inc. ; H. D. Smith; and Takeda Pharmaceuticals America, Inc.